Activation of phospholipase A2 by low levels of fluoride in THP1 macrophages via altered Ca2+ and cAMP concentration

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 86, Issue 3, 2012, Pages 99-105

  Gutowska, I ^a   Baranowska Bosiacka, I ^b   Siennicka, A ^b   Telesinski A ^c   Stanczyk Dunaj M ^b   WesoLowska T ^b   Gassowska, M ^d   KLos P ^a   Zakrzewska, H ^c   Machalinski B ^a   Chlubek, D ^b   Stachowska, E ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Department of Biochemistry ^*  (Poland)

^c WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Arachidonic acid; Calcium; CAMP; Cytosolic PLA2; Fluoride; Macrophage; Secretory PLA2

Indexed keywords

ARACHIDONIC ACID; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNEL; CYCLIC AMP; FLUORIDE; PHOSPHOLIPASE; PHOSPHOLIPASE A2; PROTEIN KINASE C;

ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL DIFFERENTIATION; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLIC AMP BLOOD LEVEL; CYCLIC AMP CELL LEVEL; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

CALCIUM; CELLS, CULTURED; CYCLIC AMP; ENZYME ACTIVATION; HUMANS; MACROPHAGES; PHOSPHOLIPASES A2; SODIUM FLUORIDE;

EID: 84858441161     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.02.002     Document Type: Article

References (62)

1. Diaza B.L., Arm J.P. Phospholipase A2. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:87-97.
2. Dessen A., Tang J., Schmidt H., et al. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell 1999, 97:349-360.
3. Sapirstein A., Bonventre J.V. Specific physiological roles of cytosolic phospholipase A2 as defined by gene knockouts. Biochim. Biophys. Acta 2000, 1488:139-148.
4. Alaoui-El-Azher M., Havet N., Singer M., Dumarey C., Touqui L. Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages. Evidence for the eicosanoid-independent pathway. Eur. J. Biochem. 2000, 267:3633-3639.
5. Kuwata H., Yamamoto S., Miyazaki Y., et al. Studies on a mechanism by which cytosolic phospholipase A2 regulates the expression and function of type IIA secretory phospholipase A2. J. Immunol. 2000, 165:4024-4031.
6. Hernandez M., Fuentez L., Fernandez-Aviles F.J., Crespo M.S., Nieto M.L. Secretory phospholipase A(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: potential relevance for atherogenesis. Circ. Res. 2002, 90:38-45.
7. Divchev D., Schieffer B. The secretory phospholipases A2 group IIA: a missing link between inflammation, activated rennin-angiotensin system, and atherogenesis?. Vasc. Health Risk Manage. 2008, 4:597-604.
8. Lessner S.M., Prado H.L., Waller E.K., Galis Z.S. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 2002, 160:2145-2155.
9. Barbier O., Arreola-Mendoza L., Del Razo L.M. Molecular mechanisms of fluoride toxicity. Chem.-Biol. Interact. 2010, 188:319-333.
10. Park S., Ajtai K., Burghardt P. Inhibition of myosin ATPase by metal fluoride complexes. Biochem. Biophys. Acta 1999, 1430:127-140.
11. Vani M.L., Reddy K.P Effects of fluoride accumulation on some enzymes of brain and gastrocnemius muscle of mice. Fluoride 2000, 33:17-26.
12. Gutowska I., Baranowska-Bosiacka I., Baśkiewicz M., et al. Fluoride as a pro-inflammatory factor and inhibitor of ATP bioavailability in differentiated human THP1 monocytic cells. Toxicol. Lett. 2010, 196:74-79.
13. Poureslami H.M., Khazaeli P., Noori G.R. Fluoride in food and water consumed in Koohbanan (Kuh-E-Banan), Iran. Fluoride 2008, 41:216-219.
14. Kalyanalakshmi P., Vijayabhaskar M., Dhananjaya Naidu M. Lipid peroxidation and antioxidant enzyme status of adult males with skeletal fluorosis in Andhra Pradesh, India. Fluoride 2007, 40:42-45.
15. Izquierdo-Vega J.A., Sánchez-Gutiérrez M., Del Razo L.M. Decreased in vitro fertility in male rats exposed to fluoride-induced oxidative stress damage and mitochondrial transmembrane potential loss. Toxicol. Appl. Pharmacol. 2008, 230:352-357.
16. Vendrov A.E., Hakim Z.S., Madamanchi N.R., Rojas M., Madamanchi C., Runge M.S. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler. Thromb. Vasc. Biol. 2007, 2714-2721.
17. Niessen H.W., Krijnen P.A., Visser C.A., Meijer C.J., Hack C.E. Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?. Cardiovasc. Res. 2003, 60:68-77.
18. Flora S.J., Pachauri V., Mittal M., Kumar D. Interactive effect of arsenic and fluoride on cardio-respiratory disorders in male rats: possible role of reactive oxygen species. Biometals 2011, 24:615-628.
19. Rønneberg A. Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes-part III: mortality from circulatory and respiratory diseases. Occup. Environ. Med. 1995, 52:255-261.
20. Dhatrak S.V., Nandi S.S. Risk assessment of chronic poisoning among Indian metallic miners. Indian J. Occup. Environ. Med. 2009, 13:60-64.
21. Fu Y., Luo N., Lopes-Virella M.F., Garvey W.T. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 2002, 165:259-269.
22. Zawierta J., Dabkowska E., Jakubowska K., Olszewska M., Noceń I. The fluorine, iron, copper, zinc and selenium contents in plasma of healthy people living in Szczecin and its vicinity. Met. Fluorine 1998, 200-205.
23. Opydo-Szymaczek J., Borysewicz-Lewicka M. Variations in concentration of fluoride in blood plasma of pregnant women and their possible consequences for amelogenesis in a fetus. Homo 2006, 57:295-307.
24. Nandi A., Chandi D., Lechesa R., et al. Bifenthrin causes neurite retraction in the absence of cell death: a model for pesticide associated neurodegeneration. Med. Sci. Monit. 2006, 12:BR169-BR173.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
26. Winkler J.D., Bolognese B.J., Roshak A.K., Sung A.K., Marshall L.A. Evidence that 85kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet activating factor in human monocytes. Biochim. Biophys. Acta 1997, 1346:173-184.
27. Folch J., Lees M., Stanley G.H.Sloane A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-499.
28. R. Holman (Ed.), Progress in the chemistry of fats and other lipids, Chromatography, vol. VIII (Part 3), Pergamon Press, New York, 1966.
29. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
30. Lester C., Nikogosian K., Shrestha R., Tucker C. Atherosclerotic assault. Eukaryon 2006, 2:40-46.
31. Wessel K., Resch K., Kaever V. Aluminium fluoride enhances phospholipase A2 activity and eicosanoid synthesis in macrophages. Eicosanoids 1989, 2:223-227.
32. Goldman R., Granot Y., Zor U. A pleiotropic effect of fluoride on signal transduction in macrophages: is it mediated by GPT-binding proteins?. J. Basic Clin. Physiol. Pharmacol. 1995, 6:79-94.
33. Dodam J.R., Olson N.C. Effect of fluoride on cardiopulmonary function and release of eicosanoids in pigs. J. Appl. Physiol. 1995, 78:569-577.
34. Mallat Z., Benessiano J., Simon T., et al. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1177-1183.
35. A. Shashi, M. Bhardwaj, Study on blood biochemical diagnostic indices for hepatic function biomarkers in endemic skeletal fluorosis, Biol. Trace Elem. Res., 2011 (online first).
36. Houdijk A.P., Van Leeuwen P.A., Adolfs M.J., Bonta I.L. GTP-related difference in cyclic AMP production between resident and inflammatory human peritoneal macrophages. Int. J. Tissue React. 1991, 13:279-285.
37. 3F and NaF in intact rat hepatocytes and plasma membrane fractions. Fluoride 1984, 17:210-217.
38. Kornegay D., Pennigton S. A review of the effect of fluoride ion on adenyl cyclase. Fluoride 1973, 6:19-32.
39. 2+-triggered molecular switch. Cell 1986, 44:861-870.
40. 2+ and phosphorylation. Biochem. J. 1995, 311:189-195.
41. Hanasaki K., Yamada K., Yamamoto S., et al. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. J. Biol. Chem. 2002, 277:29116-29124.
42. 2+-mediated p38 MAPK activation and mitochondrial depolarization. Toxicol. Lett. 2009, 185:102-109.
43. 2+. Br. J. Pharmacol. 2003, 139:1014-1022.
44. Dennis E.A., Rhee S.G., Billah M.M., Hannuns Y.A. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 1991, 5:2068-2077.
45. Qui Z.H., Gijon M.A., de Carvalho M.S., Spencer D.M., Leslie C.C. The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophage. J. Biol. Chem. 1998, 273:8203-8211.
46. Murao H., Sakagami N., Iguchi T., Murakami T., Suketa Y. Sodium fluoride increases intracellular calcium in rat renal epithelial cell line NRK-52E. Biol. Pharm. Bull. 2000, 23:581-584.
47. 2+-ATPase of kidney. Biol. Trace Elem. Res. 2007, 116:279-288.
48. Dieter P., Fitzke E. Formation of diacylglycerol, inositol phosphates, arachidonic acid and its metabolites in macrophages. Eur. J. Biochem. 1993, 218:753-758.
49. Bogatcheva N.V., Wang P., Birukova A.A., Verin A.D., Garcia J.G.N. Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L1139-L1145.
50. Bonney R.C., Beesley J.S., Franks S. Release of arachidonic acid from human endometrial cells in culture mediated by calcium ionophore (A23187) or fluoride. J. Reprod. Fertil. 1991, 93:449-460.
51. Kovács P., Csaba G. PLA2 activity in Tetrahymena pyriformis. Effects of inhibitors and stimulators. J. Lipid Mediat. Cell Signal. 1997, 15:233-247.
52. Valentin E., Lambeau G. Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins. Biochim. Biophys. Acta 2000, 1488:59-70.
53. Berg O.G., Gelb M.H., Tsai M.D., Jain M.K. Interfacial enzymology: the secreted phospholipase A2-paradigm. Chem. Rev. 2001, 101:2613-2654.
54. 2+)-independent catalytic domain. J. Biol. Chem. 1994, 269:18239-18249.
55. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 1997, 272:16709-16712.
56. 2+ response required for continuous translocation and activation of cytosolic phospholipase A2. J. Biol. Chem. 1999, 274:5163-5169.
57. Han W.K., Sapirstein A., Hung C.C., Alessandrini A., Bonventre J.V. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J. Biol. Chem. 2003, 278:24153-24163.
58. McNish R.W., Peters-Golden M. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 1993, 196:147-153.
59. Syrbu S.I., Waterman W.H., Molski T.F.P., Nagarkatti D., Hajjar J.J., Sha'afi R.I. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. J. Immunol. 1999, 162:2334-2340.
60. Qiu Z.H., Leslie C.C. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J. Biol. Chem. 1994, 269:19480-19487.
61. Schulze-Specking A., Duyster J., Gebicke-Haerter P.J., Wurster S., Dieter P. Effect of fluoride, pertussis and cholera toxin on the release of arachidonic acid and the formation of prostaglandin E2, D2, superoxide and inositol phosphates in rat liver macrophages. Cell Signal. 1991, 3:599-606.
62. Gijo' n M.A., Spencer D.M., Siddiqi A.R., Bonventre J.V., Leslie C.C. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. J. Biol. Chem. 2000, 275:20146-20156.